Healthy Ideas, Healthy Returns is a growing platform that unites all major biomedical research organizations in the Benelux (28 institutions). HIHR events are attended by all early stage Life Science Venture Capital funds in the region and the initiative is supported by J&J Innovation and INKEF Capital.

 

 

* on line edition

HIHR-1 (2016)

HIHR-2

(2017)

HIHR-3

(2018)

HIHR-4

(05-2019)

HIHR-5

(11-2019)

HIHR-6*

(06-2020)

HIHR-7* (11-2020)

# of pitch presentations

# of informal talks/QF-sessions

8

14

11

12

12

10

9

9

9

4

# Investors / corporates

14

23

27

43

37

46

44

Affiliated PRO’s

10

16

16

22

28

28

28

 

Participating institutions

The Netherlands: Universities and Academic Hospitals of Leiden, Utrecht, Groningen, Nijmegen, Amsterdam (VU & UvA); Technical Universities of Twente and Eindhoven; Erasmus Medical Centre Rotterdam; Netherlands Cancer Institute, Hubrecht Institute, Oncode Institute and KNAW

Belgium: Universities and Academic Hospitals of Antwerp, Free university of Brussels, Ghent, Hasselt, Leuven, Liege, Mons, Namur & the Université Catholique de Louvain, Université Libre de Bruxelles; Flemish Institute for Biotechnology (VIB) & IMEC.

Luxembourg: Luxembourg Institute of Health, Luxembourg Institute of Science and Technology, University of Luxembourg.

Participating funds / companies

Aglaia Oncology Funds, Bayer AG, Biogeneration Ventures, Bioqube Ventures, BOM Brabant Ventures, Brightlands Venture Partners BV, Cascara Ventures Bvba, CD3 – Centre for Drug Design and Discovery, Curie Capital, flanders.bio, Fondation Fournier-Majoie, Forbion, Fund+, Gilde Healthcare, Gimv, Het Fonds’, imec.xpand Fund, Inkef Capital, Janssen Pharmaceutica NV, JLABS EMEA, Johnson & Johnson Innovation/ JLABS, KBC Securities, Kurma Partners, LC Patents, LRM, LSP, Lunghealth, Nextgen Ventures, NLC, Noshaq, Novalis Biotech Incubator, Novuqare Pelvic Health BV, Oncode Bridge fund, PMV, Pharma Connect Capital, Qbic II, Swanbridge Capital, Theodorus, Thuja capital management, Tuspark Capital Management Luxembourg) SARL, UCB Ventures, UCB Biopharma, UNIIQ, Utrecht Health Seed Fund, V-Bio Ventures, Vives

Spin Off companies / projects presented via HIHR

Download here the list of Spin offs / projects that have presented themselves via HIHR since 2016.

Syllabi of past HIHR editions

To get an impression of the presented projects you can download here the syllabi of our past editions:

HIHR-7*, 10 November 2020 

HIHR-6*, 10 June 2020 

HIHR-5, Leiden, 27 November 2019

HIHR-4, Ghent, 8 May 2019

HIHR-3, Utrecht, 9 April 2018

HIHR-2, Rotterdam, 8 May 2017

HIHR-1, Amsterdam, 25 April 2016

*Online editions

 

 

 

We look forward to meeting you at one of our events!

Participating academic institutions in the Benelux, incl their UMC’s

Radboud umc
Wageningen University & Research

Preferred partner

Silver partners

LC Patents - Arnold & Siedsma

HIHR supporters